Cue Biopharma, Inc. - Common Stock, par value $0.001 per share (CUE)

CUSIP: 22978P106

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 7 signals
Share change
+1,288,884
Put/Call ratio
51%
SEC-reported price per share
$4.88
Indexed holders
97
Value change
+$4,491,451
Number of buys
48
Open additional details 1 more signal available
Number of sells
36
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
7,559,966

Security key

22978P106

Report period

Q1 2022

Indexed institutions

97

Top holders

10

Ownership snapshot

Top reported holders of CUE - Cue Biopharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
Nantahala Capital Managem...
Comparable rows
0/15
Latest evidence
31 Dec 2021
13F Highest disclosed value: $28,724,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Nantahala Capital Management, LLC has the largest disclosed position value at $28.72M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nantahala Capital Management, LLC's linked filing trail.
Disclosed position value Top 5
Nantahala Capital Management, LLC $28.72M
BlackRock Finance, Inc. $25.9M
STATE STREET CORP $18.8M
VANGUARD GROUP INC $17.55M
Slate Path Capital LP $16.78M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$28,724,000
2,539,700 shares
— 31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$25,903,000
2,290,269 shares
— 31 Dec 2021
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$18,800,000
1,662,252 shares
— 31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$17,546,000
1,551,314 shares
— 31 Dec 2021
Slate Path Capital LP
13F
Company
13F
—
denominator unverified
$16,780,000
1,483,619 shares
— 31 Dec 2021
DIMENSIONAL FUND ADVISORS LP
13F
Company
13F
—
denominator unverified
$9,606,000
849,343 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
97
Shares
17,812,661
Indexed holders
97
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 indexed holders
88
Q1 2022 indexed holders
97
Indexed holder difference
9
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .